Report Description:

Global Markets Direct’s, ‘HumanPapillomavirusInfections – Pipeline Review, H2 2015’, provides an overview of the Human Papillomavirus Infections’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Human Papillomavirus Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Human Papillomavirus Infections and special features on late-stage and discontinued projects.

Browse Full Report with Toc Visit:

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Category: Main topic classifications

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


  • The report provides a snapshot of the global therapeutic landscape of Human Papillomavirus Infections
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Human Papillomavirus Infections and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Human Papillomavirus Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Human Papillomavirus Infections pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Business Survey: Human Papillomavirus Infections Market to 2015 Trends and Forecast

Click Here To Download Detail Report:

Reasons to buy:

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Human Papillomavirus Infections
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Human Papillomavirus Infections pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 6

Introduction 7

Global Markets Direct Report Coverage 7

Human Papillomavirus Infections Overview 8

Therapeutics Development 9

Pipeline Products for Human Papillomavirus Infections – Overview 9

Pipeline Products for Human Papillomavirus Infections – Comparative Analysis 10

Human Papillomavirus Infections – Therapeutics under Development by Companies 11

Human Papillomavirus Infections – Therapeutics under Investigation by Universities/Institutes 13

Human Papillomavirus Infections – Pipeline Products Glance 14

Late Stage Products 14

Clinical Stage Products 15

Early Stage Products 16

Unknown Stage Products 17

Human Papillomavirus Infections – Products under Development by Companies 18

Human Papillomavirus Infections – Products under Investigation by Universities/Institutes 22

Human Papillomavirus Infections – Companies Involved in Therapeutics Development 23

3M Drug Delivery Systems 23

Admedus Ltd 24

Agilvax, Inc. 25

Astex Pharmaceuticals, Inc. 26

Beijing Minhai Biotechnology Co., Ltd 27

Bharat Biotech International Limited 28

Biogenomics Limited 29

BioMAS Ltd. 30

Biota Pharmaceuticals, Inc. 31

Chongqing Zhifei Biological Products Co., Ltd. 32

Crucell N.V. 33

EpiPharm AG 34

FluGen, Inc. 35

Foamix Pharmaceuticals Ltd. 36

G&E Herbal Biotechnology Co., Ltd. 37

Genticel S.A. 38

Helix BioPharma Corp. 39

Immunservice GmbH 40

Indian Immunologicals Limited 41

Kaketsuken K.K. 42

LEO Pharma A/S 43

MediGene AG 44

NanoViricides, Inc. 45

Nielsen Biosciences, Inc. 46

All Reports Of This Publisher:

About Acute Market Reports:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.  We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.

Contact Us:
Chris Paul
Sales Manager
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Web: AcuteMarketReports